Patents by Inventor Vijay Koya

Vijay Koya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200215266
    Abstract: A system may include an input device configured to receive a signal indicative of elevated glucose in a patient, and an electrical stimulator configured to electrically stimulate at least one skeletal muscle. The system may further include a controller operably connected to the electrical stimulator. The controller may be configured for delivering a glucose therapy in response to the signal by controlling the electrical stimulator. The system may be configured to deliver the therapy in combination with other glucose therapies, and the therapy may be titrated based on a sensed parameter or patient feedback.
    Type: Application
    Filed: January 2, 2020
    Publication date: July 9, 2020
    Inventors: Vijay Koya, Bryan Allen Clark, Keith R. Maile, Michael J. Kane, Jeffrey E. Stahmann, Elizabeth Mary Annoni
  • Publication number: 20200069366
    Abstract: A system and method for denervation where a catheter includes a radially expandable member, the radially expandable member including an exterior surface, a plurality of electrodes on the exterior surface configured for delivery of energy during a denervation procedure in a vessel, and a chemical agent coating on the exterior surface, wherein the chemical agent inhibits or prevents nerve regeneration. The radially expandable member is configured to have a first unexpanded configuration and a second expanded configuration, and is configured to bring the exterior surface in contact with a wall of a vessel when it is in the expanded configuration.
    Type: Application
    Filed: August 28, 2019
    Publication date: March 5, 2020
    Inventors: Bryan Allen Clark, Vijay Koya, Elizabeth M. Annoni, Hong Cao
  • Publication number: 20190254740
    Abstract: Devices, systems, and methods for regulating glucose levels, including treating diabetes, in accordance with the present disclosure may include a catheter having an expandable or inflatable portion, one or more electrodes disposed on the expandable or inflatable portion of the catheter, wherein the electrodes are configured to deliver energy to a patient's gastrointestinal tract, and a drug delivery mechanism for delivering a drug therapy subsequent to energy delivery by the electrodes. A method for regulating glucose levels according to the present disclosure may include inserting a catheter into a patient's gastrointestinal tract, positioning the catheter in a duodenum of the patient's gastrointestinal tract, expanding or inflating a portion of the catheter in the duodenum, the expandable or inflatable portion of the catheter including electrodes, applying energy to the duodenum via the electrodes to ablate tissue of the duodenum, and delivering a drug therapy to the ablated tissue of the duodenum.
    Type: Application
    Filed: February 19, 2019
    Publication date: August 22, 2019
    Inventors: Vijay Koya, Elizabeth M. Annoni, Bryan A. Clark, Bruce Forsyth, Hong Cao, Matthew R. DeWitt, Kyle H. Srivastava
  • Publication number: 20190125226
    Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.
    Type: Application
    Filed: November 2, 2018
    Publication date: May 2, 2019
    Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
  • Publication number: 20190125227
    Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
    Type: Application
    Filed: November 2, 2018
    Publication date: May 2, 2019
    Inventors: Vijay Koya, Bryan Allen Clark, Kyle Harish Srivastava, Michael X. Govea, Elizabeth Mary Annoni
  • Publication number: 20120039919
    Abstract: As described below, the present invention features compositions and methods featuring Pdx-1 polypeptides and fragments thereof for the diagnosis, prevention and treatment of diabetes.
    Type: Application
    Filed: August 5, 2011
    Publication date: February 16, 2012
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Lijun Yang, Vijay Koya, Shi-Wu Li